Skip to main content
. 2023 Aug 11;13:1209799. doi: 10.3389/fonc.2023.1209799

Figure 1.

Figure 1

The lesions on computed tomography. (A, B) were before treatment of aletinib. (C, D) were partial response after 8 weeks treatment of aletinib. (E, F) were progressive disease after 11 months treatment of ALK-TKI.